EAST MEADOW, N.Y. (CBSNewYork) — A teen returned to Nassau College Medical Middle on Friday to thank the employees that saved his life.
Docs consider a standard pimples drug might have triggered his dysfunction.
As CBS2’s Carolyn Gusoff reported, phrases don’t come straightforward for Devin O’Rourke, however his face – truly his pores and skin – inform his exceptional story of restoration.
Simply six months in the past, it was all eaten away by a extreme pores and skin dysfunction.
His mom, Eileen, stated her worst worry would have been burying her son.
“I thank god that we’re not,” she stated.
Devin’s nightmare began with sores in his mouth and shortly spiraled. His eyes, nostril and mouth have been all beneath assault.
Nasssau College Medical Middle’s burn unit specialists recognized him with Stevens-Johnson syndrome, or poisonous epidermal necrolysis.
“He was as sick as a younger man could possibly be. He fought for his life,” Dr. Louis Riina stated. “The ache that he needed to expertise is meaningless for any of us. He shed the whole thing of his pores and skin.”
“There have been days we walked in and stated, ‘he’s not going to make it.’ However he did, and he fought, and he appears good,” Dr. Peter Ciminera stated.
The suspected explanation for this very uncommon dysfunction was the quite common drug tetracycline, which is used to deal with pimples.
“It was simply common pimples, and that is the place he obtained the Stevens-Johnson from,” his mom stated.
It was a life threatening allergic response.
“There’s a big record of medicines that do trigger this syndrome,” Dr. Victor Politi stated.
From the brink of demise, Devin is now celebrating life and giving thanks on his fifteenth birthday.
“I recognize them a lot for the whole lot they did, saving my life,” he stated.
Docs name this a cautionary story. All medicine may cause hostile reactions, and pores and skin blistering ought to be promptly recognized.
Devin continues to be therapeutic however is heading again to highschool in Levittown within the fall.
Stevens-Johnson syndrome impacts fewer than six individuals per million.